Masimo Past Earnings Performance
Past criteria checks 3/6
Masimo's earnings have been declining at an average annual rate of -43.9%, while the Medical Equipment industry saw earnings growing at 10.3% annually. Revenues have been growing at an average rate of 9.1% per year. Masimo's return on equity is 28.8%, and it has net margins of 13.6%.
Key information
-43.92%
Earnings growth rate
-43.35%
EPS growth rate
| Medical Equipment Industry Growth | 8.90% |
| Revenue growth rate | 9.13% |
| Return on equity | 28.80% |
| Net Margin | 13.60% |
| Last Earnings Update | 03 Jan 2026 |
Recent past performance updates
Recent updates
Masimo: Danaher Acquisition Saves The Company From Lackluster Performance
Feb 17Is Masimo Corporation (NASDAQ:MASI) Potentially Undervalued?
Sep 12
Calculating The Fair Value Of Masimo Corporation (NASDAQ:MASI)
Aug 01Is Masimo (NASDAQ:MASI) Using Too Much Debt?
Jun 19Is It Time To Consider Buying Masimo Corporation (NASDAQ:MASI)?
May 29Masimo: Priced Dearly Given Uncertainty
Apr 25Pinning Down Masimo Corporation's (NASDAQ:MASI) P/S Is Difficult Right Now
Apr 24Masimo: A Stellar Performance After The Dust Has Settled
Dec 11Masimo Corporation: Too Much Uncertainty For Now
Sep 25
Sensors Surge And Decisive Shifts Set To Soar In Healthcare Triumph
Increased hospital admissions and successful hospital conversions to Masimo products are anticipated to continue driving healthcare revenue growth.Revenue & Expenses Breakdown
How Masimo makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 03 Jan 26 | 1,527 | 208 | 511 | 126 |
| 27 Sep 25 | 2,182 | -240 | 749 | 203 |
| 28 Jun 25 | 2,154 | -270 | 770 | 210 |
| 29 Mar 25 | 2,127 | -290 | 753 | 219 |
| 28 Dec 24 | 1,395 | 16 | 518 | 146 |
| 28 Sep 24 | 1,576 | 115 | 538 | 152 |
| 29 Jun 24 | 1,711 | 101 | 558 | 161 |
| 30 Mar 24 | 1,823 | 92 | 588 | 163 |
| 30 Dec 23 | 1,276 | 108 | 451 | 131 |
| 30 Sep 23 | 2,116 | 89 | 690 | 192 |
| 01 Jul 23 | 2,187 | 116 | 707 | 198 |
| 01 Apr 23 | 2,297 | 118 | 728 | 206 |
| 31 Dec 22 | 2,036 | 144 | 641 | 191 |
| 01 Oct 22 | 1,746 | 171 | 559 | 170 |
| 02 Jul 22 | 1,505 | 191 | 487 | 153 |
| 02 Apr 22 | 1,244 | 223 | 408 | 139 |
| 01 Jan 22 | 1,239 | 230 | 395 | 137 |
| 02 Oct 21 | 1,207 | 232 | 382 | 136 |
| 03 Jul 21 | 1,177 | 224 | 371 | 129 |
| 03 Apr 21 | 1,173 | 229 | 376 | 126 |
| 02 Jan 21 | 1,144 | 240 | 369 | 119 |
| 26 Sep 20 | 1,096 | 223 | 361 | 110 |
| 27 Jun 20 | 1,047 | 222 | 351 | 106 |
| 28 Mar 20 | 976 | 211 | 330 | 99 |
| 28 Dec 19 | 938 | 196 | 315 | 93 |
| 28 Sep 19 | 913 | 190 | 306 | 91 |
| 29 Jun 19 | 895 | 198 | 297 | 87 |
| 30 Mar 19 | 877 | 197 | 289 | 83 |
| 29 Dec 18 | 858 | 194 | 285 | 81 |
| 29 Sep 18 | 843 | 139 | 290 | 76 |
| 30 Jun 18 | 826 | 118 | 284 | 71 |
| 31 Mar 18 | 807 | 119 | 280 | 67 |
| 30 Dec 17 | 790 | 125 | 273 | 65 |
| 30 Sep 17 | 766 | 348 | 271 | 60 |
| 01 Jul 17 | 740 | 340 | 263 | 61 |
| 01 Apr 17 | 720 | 325 | 260 | 59 |
| 31 Dec 16 | 713 | 311 | 255 | 58 |
| 01 Oct 16 | 672 | 109 | 255 | 58 |
| 02 Jul 16 | 657 | 101 | 257 | 57 |
| 02 Apr 16 | 640 | 90 | 254 | 55 |
| 02 Jan 16 | 623 | 83 | 253 | 56 |
| 03 Oct 15 | 623 | 80 | 244 | 58 |
| 04 Jul 15 | 613 | 76 | 246 | 58 |
| 04 Apr 15 | 596 | 70 | 246 | 58 |
Quality Earnings: MASI has high quality earnings.
Growing Profit Margin: MASI became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: MASI's earnings have declined by 43.9% per year over the past 5 years.
Accelerating Growth: MASI has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: MASI has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (6.8%).
Return on Equity
High ROE: MASI's Return on Equity (28.8%) is considered high.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/03/12 22:18 |
| End of Day Share Price | 2026/03/12 00:00 |
| Earnings | 2026/01/03 |
| Annual Earnings | 2026/01/03 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Masimo Corporation is covered by 22 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Michael Polark | Baird |
| Charley Jones | Barrington Research Associates, Inc. |
| Ravi Misra | Berenberg |